The mobile team of the Center for Primary Health Care conducted the first stage of vaccination of the company’s staff.
In total, 30% of employees were vaccinated during the first stage. According to the company’s executive director Volodymyr Kyselov, “it is necessary to form a herd immunity so that in a pandemic, a plant that produces important pharmaceutical products for society would work stably and in harmony”.
The Moderna vaccine was developed by the American biotechnology company Moderna, Inc. During the tests, the vaccine proved its effectiveness by 94.1%. The European Medicines Agency has authorized its use in all countries of the European Union.